Medallion Resources Ltd (MLLOF) 0.0150

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medallion Resources Ltd (MLLOF) 0.0150 $MLLOF

Medallion's Metallurgical Testing Confirms Process Design Plans
Marketwired - Wed May 20, 5:01AM CDT
Medallion Resources Ltd (TSX VENTURE: MDL)(OTCQB: MLLOF) ("Medallion" or the "Company", today announced that it has made significant progress on its lab-scale metallurgical testing to extract rare earths from beach sand monazite. This recent work, undertaken by the Company's Chief Technical Advisor Dr Bill Bird and a Denver-based metallurgical consultancy, confirms Medallion's caustic-route metallurgical process plans and establishes an important step toward full process refinement and commercialization.
MDL.VN: 0.015 (-0.005)

Medallion Closes $325,000 Private Placement
Marketwired - Fri May 01, 5:00AM CDT
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
MDL.VN: 0.015 (-0.005)

Private Placement Increased to $325,000
Marketwired - Mon Apr 20, 10:00AM CDT
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
MDL.VN: 0.015 (-0.005)

Medallion Increases Private Placement to $300,000
Marketwired - Thu Apr 09, 5:00AM CDT
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
MDL.VN: 0.015 (-0.005)

Medallion Announces $250,000 Private Placement
Marketwired - Wed Apr 08, 5:00AM CDT
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
MDL.VN: 0.015 (-0.005)

Medallion Resources Appoints R+R Consulting
Marketwired - Mon Mar 02, 5:00AM CST
Medallion Resources Ltd (TSX VENTURE: MDL) (OTCQB: MLLOF) ("Medallion" or the "Company" today announced that it has appointed R&R Consulting ("R&R" to provide investor relations services to the Company.
MDL.VN: 0.015 (-0.005)

Medallion Provides Business Strategy Update
Marketwired - Thu Jan 29, 5:02AM CST
Medallion Resources Ltd (TSX VENTURE: MDL)(OTCQB: MLLOF) ("Medallion" or the "Company", today announced the acceleration of its evaluation of jurisdictions outside the Middle East in order to expedite the approval, construction, and operation of its proposed monazite-based rare-earth processing facility.
MDL.VN: 0.015 (-0.005)

Medallion Initiates Laboratory-Scale Rare Earth Monazite Processing
Marketwired - Thu Oct 30, 5:31AM CDT
Medallion Resources Ltd. (TSX VENTURE: MDL)(OTCQB: MLLOF)(FRANKFURT: MRD) ("Medallion" or the "Company" today announced the initiation of lab-scale extraction tests of rare earths from monazite. The extraction will use the standard commercial monazite process to produce a rare-earth chemical concentrate, co-products and waste materials of the type expected from a commercial operation. The rare-earth concentrate will provide a sample product for discussions with potential customers.
MRD: 17.62 (-0.16), MDL.VN: 0.015 (-0.005)

Medallion Announces Management Changes and Reports 2014 Annual Meeting of Shareholders
Marketwired - Wed Oct 08, 5:31AM CDT
Medallion Resources Ltd. (TSX VENTURE: MDL)(OTCQB: MLLOF)(FRANKFURT: MRD) ("Medallion" or the "Company", today announced that Mr Donald Lay has been appointed CEO and Dr Bill Bird will serve as Medallion's new Chief Technical Advisor. These changes will enhance the Company's ability to move quickly in advancing key financial relationships and securing long-term monazite feedstock agreements, as the Company prepares for economic studies on its proposed rare-earth processing facility.
MRD: 17.62 (-0.16), MDL.VN: 0.015 (-0.005)

Medallion Resources Announce Extension of MOUs
Marketwire - Mon Sep 08, 5:31AM CDT
Medallion Resources Ltd (TSX VENTURE: MDL)(OTCQB: MLLOF)(FRANKFURT: MRD) ("Medallion" or the "Company" today announced that it has once again completed extensions of the existing Memorandums of Understanding (the "MOUs" with Oman-based Takamul Investment Company ("Takamul" and Jordan-based Arab Mining Company ("Arab Mining".
MRD: 17.62 (-0.16), MDL.VN: 0.015 (-0.005)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Man Group PLC Highlights Its Strategic Disclosures on Tritax REIT

Updated Category News Views 148

Strategic Position Disclosure by Man Group PLC Man Group PLC is actively sharing its significant interests in the securities market, particularly focusing on its involvement with Tritax Big Box REIT plc. As a key player in the investment landscape, this disclosure marks an important step for the company regarding its strategic holdings. Key Information Pertaining to the...

Continue Reading
TalentLMS and Epignosis Lead the Way in GDPR Compliance

Updated Category News Views 720

TalentLMS and Epignosis Set the Standard for GDPR Compliance TalentLMS, along with its parent company Epignosis, has continuously led the way in providing a fully compliant Learning Management System (LMS) with regards to the General Data Protection Regulation (GDPR). Recent developments affirm that TalentLMS remains the only LMS globally to uphold its commitment to this...

Continue Reading
Zillow and Esusu Forge New Path to Boost Renters' Credit Scores

Updated Category News Views 283

Building Credit for Renters with Zillow and Esusu The recent collaboration between Zillow and Esusu marks a significant step towards empowering renters across the country to build their credit. This partnership allows any renter to report their on-time rent payments, significantly enhancing their credit profiles, for just $20 a year. How the Partnership Works Starting...

Continue Reading
iCrowdNewswire Leverages DeepL for Enhanced Global Communication

Updated Category News Views 121

iCrowdNewswire Enhances Multilingual Capabilities iCrowdNewswire, a prominent international press release distribution company, has embarked on a transformative journey to improve its multilingual services through the introduction of the DeepL API. The integration of DeepL's cutting-edge language AI technology has significantly boosted iCrowdNewswire’s ability to...

Continue Reading
Celebrating Excellence: Top Surgeons Recognized in Endocrine Care

Updated Category News Views 82

Exceptional Recognition for Leading Surgeons in Endocrine Surgery Dr. Jim Norman and Dr. Gary Clayman Acknowledged as Premier Specialists The Hospital for Endocrine Surgery is proud to announce that two of its distinguished surgeons, Dr. Jim Norman and Dr. Gary Clayman, have been honored in the prestigious Castle Connolly Top Doctors list for 2025. This remarkable...

Continue Reading